We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Prevention of Iron Deficiency in 2nd Year of Life

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00479102
Recruitment Status : Unknown
Verified May 2007 by Soroka University Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : May 25, 2007
Last Update Posted : May 25, 2007
Information provided by:
Soroka University Medical Center

Brief Summary:
Healthy babies(age 8-18 months) following a routine blood count, with no anemia or iron deficiency, will be randomly placed in two groups. Group 1 will receive a 3 months preventive dose of an iron preparation (Ferripel 3 iron polysaccharide complex). Group 2 will be followed up as a control group. Following a nutritional questionnair, parents of all babies will receive instruction regarding appropriate nutrition in the 2nd year of life. A follow-up blood count will be taken from all participating babies 3 months after recruitment. The study aims to evaluate effectiveness of iron supplementation in the 2nd year of life. The hypothesis is that babies who receive iron supplementation in the 2nd year of life are less likely to develop iron deficiency or anemia.

Condition or disease Intervention/treatment Phase
Iron Deficiency Anemia Drug: Ferripel-3 - iron polysaccharide complex for prevention Phase 4

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Effectiveness of Iron Supplementation in the Second Year of Life for Prevention of Iron Deficiency
Study Start Date : May 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anemia Iron
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   8 Months to 18 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy babies without iron deficiency

Exclusion Criteria:

  • Babies with iron deficiency or chronic diseases, premature babies and babies with hereditary hematological disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00479102

Contact: Hanna Shalev, MD 972-52-8504058 hannash@clalit.org.il

Clalit Health Services Child Health Center Not yet recruiting
Rahat, Israel
Contact: Hanna Shalev, MD    972-52-8504058    hannash@clalit.org.il   
Sponsors and Collaborators
Soroka University Medical Center
Principal Investigator: Hanna Shalev, MD Clalit Health Services

ClinicalTrials.gov Identifier: NCT00479102     History of Changes
Other Study ID Numbers: sor448707ctil
First Posted: May 25, 2007    Key Record Dates
Last Update Posted: May 25, 2007
Last Verified: May 2007

Keywords provided by Soroka University Medical Center:
Iron supplementation

Additional relevant MeSH terms:
Anemia, Iron-Deficiency
Anemia, Hypochromic
Hematologic Diseases
Iron Metabolism Disorders
Metabolic Diseases
Trace Elements
Growth Substances
Physiological Effects of Drugs